ARA290 CAS: 1208243-50-8

ARA290, derived from EPO, is utilized in medical settings for its therapeutic potential in treating inflammatory and autoimmune conditions. It functions by binding to the innate repair receptor (IRR) and modulating inflammatory responses, thereby reducing tissue damage and promoting healing. ARA290 has shown promise in clinical trials for conditions such as diabetic neuropathy and inflammatory bowel disease, where it aids in alleviating symptoms and improving patient outcomes. Ongoing research aims to further elucidate its mechanisms and expand its applications in managing chronic inflammatory disorders effectively.